Roivant Sciences is trading at $33.35 (-4.03%) amid broad risk-off sentiment as higher oil prices and Treasury yields raise inflation concerns.
- Reuters reported Thursday that oil jumped and yields rose, weighing on U.S. stock futures.
- Biotech ETF XBI was down 2.04% during the session.
- No clear company-specific announcement has been identified; available evidence points to market and sector pressure rather than a Roivant-specific catalyst.